GNG_HomeBanner_v6.jpg

We Develop and Commercialize New Agricultural Products

Our first range of Agriplier™ products is based on non-living, non-toxic, microbe derived by-products which contain specific metabolites and stimulants that significantly improve many crops.

Agriplier™ products can be easily integrated into multiple seed treatment processes, as well as utilized as a soil amendment. As a non-living product, a key differentiator of Agriplier™ is that it can be used as an additive solution to both existing chemical and living biological products.

Notably, in the 2013 IPSA trials, GGI products were the #1 performing yield enhancement seed treatment product across both Corn and Soybean, increasing yield over the current commercial treatment package. Independent researchers also observe visual improvements in early season plant vigor.

GGI is working with a limited number of industry partners and end-users to bring the Agriplier™ Technology to market, whether via the distribution of Agriplier™ products or by integrating Agriplier™ Technology into existing product offerings.

Please Contact Us if you would like to discuss joining our group of partners or to apply to trial the Agriplier™ products in order to observe their benefits first-hand.

Soybean vigor.jpg

  • Agriplier® was the top performing product for the second consecutive year in the 2014 IPSA Soybean seed enhancement trials;
  • Agriplier® also delivered strong results in Corn, adding an average of 3.4 Bu / Acre during the 2014 IPSA trials;
  • Yield enhancements achieved are additive to today’s market standard seed treatment technologies; Agriplier® integrates easily with these current treatments.

Austin, Texas. April 2015: Green & Grow Inc. (GGI) is pleased to announce that its Agriplier® Technology completed a second successful year of testing in the IPSA[1] Corn and Soybean Seed Treatment trials in addition to generating compelling...

more
Otter Capital.jpg

Green & Grow Inc. (GGI) has raised an additional $6 million in Series B funding and secured Otter Capital as a significant new partner. Otter Capital’s expertise and investment capital will accelerate commercialization of GGI’s Agriplier™ technology, building on recent compelling field trial results across multiple crop types.

“Since our first meeting, we have been impressed with Otter Capital’s knowledge and commitment to the biological product space,” said Alan Sobba President and CEO of GGI. “We look forward to John’s valuable input and guidance as we work together to complete the commercialization of our exciting technology.”

GGI’s...

more